Journal article
Comparative effectiveness and cardiovascular safety of abaloparatide and teriparatide in postmenopausal women new to anabolic therapy: A US administrative claims database study
- Abstract:
- Following 18 months of treatment, abaloparatide was comparable to teriparatide for prevention of NVF and similar cardiovascular safety was demonstrated between cohorts.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 826.5KB, Terms of use)
-
- Publisher copy:
- 10.1007/s00198-022-06413-y
Authors
- Publisher:
- Springer
- Journal:
- Osteoporosis International More from this journal
- Volume:
- 33
- Issue:
- 8
- Pages:
- 1703-1714
- Publication date:
- 2022-05-07
- DOI:
- EISSN:
-
1433-2965
- ISSN:
-
0937-941X
- Language:
-
English
- Keywords:
- Pubs id:
-
1256849
- Local pid:
-
pubs:1256849
- Source identifiers:
-
W4229333373
- Deposit date:
-
2026-04-24
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2022
If you are the owner of this record, you can report an update to it here: Report update to this record